Patents by Inventor Gary Roubin
Gary Roubin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230157679Abstract: Methods for sealing a percutaneous puncture in a wall of a body passageway are disclosed herein. The methods include inserting a deployment instrument into the puncture via a toggle along the guidewire, and actuating the deployment instrument to move the first component and the second component relative to each other such that the toggle abuts the wall of the artery proximate the puncture to seal the puncture.Type: ApplicationFiled: January 23, 2023Publication date: May 25, 2023Applicant: Teleflex Life Sciences LimitedInventors: Greg A. Walters, Gary Roubin, Michael Thomas Nispel, Michael Austin Dotsey, Piyush Arora
-
Patent number: 11589855Abstract: A closure device for sealing a percutaneous puncture in a wall of a body passageway, the closure device including at least one of a toggle configured to engage an interior surface of the body passageway or a plug configured to engage an exterior surface of the body passageway and a guide wire configured to extend from an outside of the body to inside the body passageway, wherein at least one of the toggle and the plug is associated with the guide wire.Type: GrantFiled: July 12, 2019Date of Patent: February 28, 2023Assignee: Teleflex Life Sciences LimitedInventors: Greg A. Walters, Gary Roubin, Michael Thomas Nispel, Michael Austin Dotsey, Piyush Arora
-
Patent number: 10485524Abstract: A closure device for sealing a percutaneous puncture in a wall of a body passageway, the closure device including at least one of a toggle configured to engage an interior surface of the body passageway or a plug configured to engage an exterior surface of the body passageway and a guide wire configured to extend from an outside of the body to inside the body passageway, wherein at least one of the toggle and the plug is associated with the guide wire.Type: GrantFiled: September 6, 2012Date of Patent: November 26, 2019Assignee: Essential Medical, Inc.Inventors: Greg Walters, Gary Roubin, Michael Nispel, Mike Dotsey, Piyush Arora
-
Publication number: 20190336116Abstract: A closure device for sealing a percutaneous puncture in a wall of a body passageway, the closure device including at least one of a toggle configured to engage an interior surface of the body passageway or a plug configured to engage an exterior surface of the body passageway and a guide wire configured to extend from an outside of the body to inside the body passageway, wherein at least one of the toggle and the plug is associated with the guide wire.Type: ApplicationFiled: July 12, 2019Publication date: November 7, 2019Applicant: Essential Medical, Inc.Inventors: Greg A. WALTERS, Gary ROUBIN, Michael Thomas NISPEL, Michael Austin DOTSEY, Piyush ARORA
-
Patent number: 10383611Abstract: A closure device for sealing a percutaneous puncture in a wall of a body passageway, the closure device including at least one of a toggle configured to engage an interior surface of the body passageway or a plug configured to engage an exterior surface of the body passageway and a guide wire configured to extend from an outside of the body to inside the body passageway, wherein at least one of the toggle and the plug is associated with the guide wire.Type: GrantFiled: December 12, 2014Date of Patent: August 20, 2019Assignee: Essential Medical, Inc.Inventors: Greg A. Walters, Gary Roubin, Michael Thomas Nispel, Michael Austin Dotsey, Piyush Arora
-
Publication number: 20150335793Abstract: Devices and methods for reducing, eliminating, preventing, suppressing, or treating tissue responses to hemostatic devices e.g., biological sealants or vascular procedures are disclosed. The invention employs a combination of resorbable, biocompatible matrix materials and a variety of therapeutic agents, such as antiproliferatives or antibiotics, applied to a vascular puncture or incision to achieve hemostasis following diagnostic or interventional vascular catheterizations and to treat neointimal hyperplasia and stenosis. A matrix of a material such as collagen provides a reservoir of a therapeutic agent such as rapamycin (sirolimus) and its derivatives and analogs for delivery at a tissue site at risk for vasculoproliferation, infection, inflammation, fibrosis or other tissue responses.Type: ApplicationFiled: August 4, 2015Publication date: November 26, 2015Inventors: Sriram Iyer, Nicholas Kipshidze, Victor Nikolaychik, Gary Roubin
-
Patent number: 9132099Abstract: Devices and methods for reducing, eliminating, preventing, suppressing, or treating tissue responses to hemostatic devices e.g., biological sealants or vascular procedures are disclosed. The invention employs a combination of resorbable, biocompatible matrix materials and a variety of therapeutic agents, such as antiproliferatives or antibiotics, applied to a vascular puncture or incision to achieve hemostasis following diagnostic or interventional vascular catheterizations and to treat neointimal hyperplasia and stenosis. A matrix of a material such as collagen provides a reservoir of a therapeutic agent such as rapamycin (sirolimus) and its derivatives and analogs for delivery at a tissue site at risk for vasculoproliferation, infection, inflammation, fibrosis or other tissue responses.Type: GrantFiled: March 18, 2013Date of Patent: September 15, 2015Assignee: VASCULAR THERAPIES, INC.Inventors: Sriram Iyer, Nicholas Kipshidze, Victor Nikolaychik, Gary Roubin
-
Publication number: 20150100083Abstract: A closure device for sealing a percutaneous puncture in a wall of a body passageway, the closure device including at least one of a toggle configured to engage an interior surface of the body passageway or a plug configured to engage an exterior surface of the body passageway and a guide wire configured to extend from an outside of the body to inside the body passageway, wherein at least one of the toggle and the plug is associated with the guide wire.Type: ApplicationFiled: December 12, 2014Publication date: April 9, 2015Inventors: Greg A. Walters, Gary Roubin, Michael Thomas Nispel, Michael Austin Dotsey, Piyush Arora
-
Publication number: 20130331921Abstract: Systems and methods are disclosed for a bifurcated catheter, and more particularly, to denervation of arterial nerves using a bifurcated catheter. In embodiments, the catheter comprises, for example, a catheter shaft bifurcated into a first catheter energy member and a second catheter energy member, wherein the first catheter energy member comprises a first transducer and the second catheter energy member comprises a second transducer, and wherein the first and second transducers are configured to cause denervation of an arterial nerve of the patient.Type: ApplicationFiled: June 10, 2013Publication date: December 12, 2013Inventor: Gary Roubin
-
Publication number: 20130178895Abstract: A closure device for sealing a percutaneous puncture in a wall of a body passageway, the closure device including at least one of a toggle configured to engage an interior surface of the body passageway or a plug configured to engage an exterior surface of the body passageway and a guide wire configured to extend from an outside of the body to inside the body passageway, wherein at least one of the toggle and the plug is associated with the guide wire.Type: ApplicationFiled: September 6, 2012Publication date: July 11, 2013Applicant: ESSENTIAL MEDICAL, LLCInventors: Greg Walters, Gary Roubin, Michael Nispel, Mike Dotsey, Piyush Arora
-
Publication number: 20080086156Abstract: A method and system of embolizing an organ or vessel is disclosed. An embolization device such as a coil, balloon, spheres, stents or occlusive plaques is used. The embolization device has a surface, which may be coated with composition retaining material such as a polymer, bio-polymer or non-polymer based technology that allows sustained release of drug or material from drug eluting occlusive device. For example, an anti-angiogenic composition is coated on the application surface. The embolization device is then inserted in the vessel and embolization is enhanced by the composition.Type: ApplicationFiled: May 7, 2007Publication date: April 10, 2008Inventors: Robert Rosen, Nicholas Kipshidze, Sriram Iyer, Gary Roubin
-
Publication number: 20080058789Abstract: Structures and methods for guidance of a guide wire in a blood vessel are disclosed. The guide wire comprises a metal housing having a lumen and four or more optical fibers contained within the lumen. The methods comprise obtaining multiple signals via the guide wire and processing said signal to obtain real-time positional information as to the location of the tip in the cross-section of the blood vessel.Type: ApplicationFiled: September 5, 2007Publication date: March 6, 2008Applicant: CardioFirstInventor: Gary Roubin
-
Publication number: 20070213808Abstract: An intraluminal prosthesis is provided with a plurality of annular elements. Each annular element includes a plurality of struts and apices connected to form an annular configuration. Each annular element has a compressed state and an expanded state, and has a longitudinal dimension which is smaller in the expanded state than in the compressed state. A plurality of connecting members connect the apices of adjacent annular elements. The connecting members have a plurality of alternating segments that function to compensate for the smaller longitudinal dimension of each annular element in the expanded state. The stent may be provided with varying flexibility along its length and/or circumference, and may include segments that have different diameters.Type: ApplicationFiled: March 21, 2007Publication date: September 13, 2007Inventors: Gary Roubin, Geoffrey White, Sriram Iyer, Russell Redmond, Claude Vidal
-
Publication number: 20070213806Abstract: An intraluminal prosthesis is provided with a plurality of annular elements. Each annular element includes a plurality of struts and apices connected to form an annular configuration. Each annular element has a compressed state and an expanded state, and has a longitudinal dimension which is smaller in the expanded state than in the compressed state. A plurality of connecting members connect the apices of adjacent annular elements. The connecting members have a plurality of alternating segments that function to compensate for the smaller longitudinal dimension of each annular element in the expanded state. The stent may be provided with varying flexibility along its length and/or circumference, and may include segments that have different diameters.Type: ApplicationFiled: March 21, 2007Publication date: September 13, 2007Inventors: Gary Roubin, Geoffrey White, Sriram Iyer, Russell Redmond, Claude Vidal
-
Publication number: 20070213807Abstract: An intraluminal prosthesis is provided with a plurality of annular elements. Each annular element includes a plurality of struts and apices connected to form an annular configuration. Each annular element has a compressed state and an expanded state, and has a longitudinal dimension which is smaller in the expanded state than in the compressed state. A plurality of connecting members connect the apices of adjacent annular elements. The connecting members have a plurality of alternating segments that function to compensate for the smaller longitudinal dimension of each annular element in the expanded state. The stent may be provided with varying flexibility along its length and/or circumference, and may include segments that have different diameters.Type: ApplicationFiled: March 21, 2007Publication date: September 13, 2007Inventors: Gary Roubin, Geoffrey White, Sriram Iyer, Russell Redmond, Claude Vidal
-
Publication number: 20050004158Abstract: Devices and methods for reducing, eliminating, preventing, suppressing, or treating tissue responses to hemostatic devices e.g., biological sealants or vascular procedures are disclosed. The invention employs a combination of resorbable, biocompatible matrix materials and a variety of therapeutic agents, such as antiproliferatives or antibiotics, applied to a vascular puncture or incision to achieve hemostasis following diagnostic or interventional vascular catheterizations and to treat neointimal hyperplasia and stenosis. A matrix of a material such as collagen provides a reservoir of a therapeutic agent such as rapamycin (sirolimus) and its derivatives and analogs for delivery at a tissue site at risk for vasculoproliferation, infection, inflammation, fibrosis or other tissue responses.Type: ApplicationFiled: June 18, 2004Publication date: January 6, 2005Applicant: Vascular Therapies LLCInventors: Sriram Iyer, Nicholas Kipshidze, Victor Nikolaychik, Gary Roubin